Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erneux

Showing results (311-320 of 318) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 318 results.
Nature|May 9, 2001
The lipid phosphatase SHIP2 controls insulin sensitivityS Clément, U Krause, F Desmedt, et al.
Cell Death and Differentiation|November 26, 2011
Transfer of IP₃ through gap junctions is critical, but not sufficient, for the spread of apoptosisE Decrock, D V Krysko, M Vinken, et al.
The EMBO Journal|July 14, 2017
The <i>Shigella</i> type III effector IpgD recodes Ca<sup>2+</sup> signals during invasion of epithelial cellsChun Hui Sun, Benjamin Wacquier, Daniel I Aguilar, et al.
The Biochemical Journal|August 3, 2013
Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) is an AMPK target participating in contraction-stimulated glucose uptake in skeletal muscleYang Liu, Yu-Chiang Lai, Elaine V Hill, et al.
Physical Review. E|December 15, 2016
Slow passage through thresholds in quantum dot lasersE A Viktorov, T Erneux, E D Kolykhalova, et al.
Science Signaling|September 20, 2018
The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinasesBohumil Fafilek, Lukas Balek, Michaela Kunova Bosakova, et al.
Acta Neuropathologica|June 4, 2024
Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progressionKunie Ando, Fahri Küçükali, Emilie Doeraene, et al.
Cell Reports|March 19, 2020
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of ActomyosinSophie Uzureau, Laurence Lecordier, Pierrick Uzureau, et al.
Pageof 32

Showing results (311-320 of 318) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 318 results.
Nature|May 9, 2001
The lipid phosphatase SHIP2 controls insulin sensitivityS Clément, U Krause, F Desmedt, et al.
Cell Death and Differentiation|November 26, 2011
Transfer of IP₃ through gap junctions is critical, but not sufficient, for the spread of apoptosisE Decrock, D V Krysko, M Vinken, et al.
The EMBO Journal|July 14, 2017
The <i>Shigella</i> type III effector IpgD recodes Ca<sup>2+</sup> signals during invasion of epithelial cellsChun Hui Sun, Benjamin Wacquier, Daniel I Aguilar, et al.
The Biochemical Journal|August 3, 2013
Phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) is an AMPK target participating in contraction-stimulated glucose uptake in skeletal muscleYang Liu, Yu-Chiang Lai, Elaine V Hill, et al.
Physical Review. E|December 15, 2016
Slow passage through thresholds in quantum dot lasersE A Viktorov, T Erneux, E D Kolykhalova, et al.
Science Signaling|September 20, 2018
The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinasesBohumil Fafilek, Lukas Balek, Michaela Kunova Bosakova, et al.
Acta Neuropathologica|June 4, 2024
Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progressionKunie Ando, Fahri Küçükali, Emilie Doeraene, et al.
Cell Reports|March 19, 2020
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of ActomyosinSophie Uzureau, Laurence Lecordier, Pierrick Uzureau, et al.
Pageof 32